HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Monocarboxylate transporters and mitochondrial creatine kinase protein content in McArdle disease.

Abstract
McArdle disease (MD) is a metabolic myopathy due to myophosphorylase deficiency. We examined monocarboxylate transporters (MCT) and creatine kinase (CK) protein content in skeletal muscle from MD patients and age-matched controls to evaluate potential cellular adaptations that compensate for the loss of glycogenolysis. Our findings of higher MCT1 and mitochondrial CK suggest that proteins related to extra-muscular fuel uptake and intra-muscular energy transduction are up-regulated without change in mitochondrial mass in MD patients.
AuthorsYu Kitaoka, Daniel I Ogborn, Nicholas J Mocellin, Uwe Schlattner, Mark A Tarnopolsky
JournalMolecular genetics and metabolism (Mol Genet Metab) Vol. 108 Issue 4 Pg. 259-62 (Apr 2013) ISSN: 1096-7206 [Electronic] United States
PMID23434346 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2013 Elsevier Inc. All rights reserved.
Chemical References
  • Membrane Transport Proteins
  • Monocarboxylic Acid Transporters
  • Creatine Kinase, Mitochondrial Form
Topics
  • Creatine Kinase, Mitochondrial Form (metabolism)
  • Female
  • Glycogen Storage Disease Type V (metabolism)
  • Glycogenolysis
  • Humans
  • Male
  • Membrane Transport Proteins (metabolism)
  • Middle Aged
  • Mitochondria (enzymology, metabolism)
  • Monocarboxylic Acid Transporters (metabolism)
  • Muscle, Skeletal (metabolism)
  • Muscular Diseases (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: